Free Trial

Vincerx Pharma (VINC) SEC Filings & 10K Form

Vincerx Pharma logo
$0.05 +0.00 (+4.12%)
As of 03:50 PM Eastern

Recent Vincerx Pharma SEC Filings

DateFilerForm TypeView
05/01/2025
4:06 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:07 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:08 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:10 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:12 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:13 PM
Vincerx Pharma (Filer)
Form S-8 POS
04/30/2025
3:41 PM
Vincerx Pharma (Filer)
Form PRE 14A
04/17/2025
3:52 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
3:03 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
03/31/2025
3:02 PM
Vincerx Pharma (Filer)
Form S-3/A
03/18/2025
8:02 AM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
8:05 AM
Vincerx Pharma (Subject)
Form 425
02/12/2025
7:30 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:09 PM
Long Focus Capital Management, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:06 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/29/2025
3:05 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/23/2025
3:10 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:15 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/21/2025
3:31 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:29 PM
Vincerx Pharma (Filer)
Form 424B5
01/16/2025
4:11 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:12 PM
Vincerx Pharma (Filer)
Form 424B5
12/27/2024
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
4:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/13/2024
7:32 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/05/2024
8:15 AM
Vincerx Pharma (Filer)
Form PRE 14A
09/30/2024
5:57 AM
Vincerx Pharma (Subject)
Form SC TO-I/A
09/10/2024
3:02 PM
Vincerx Pharma (Subject)
Form SC TO-I/A
08/16/2024
3:01 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:11 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:00 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:03 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:07 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:37 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Vincerx Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

07/08/2024
3:45 PM
Vincerx Pharma (Filer)
Form DEF 14A
05/29/2024
7:54 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
7:55 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:03 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:12 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:35 PM
Bushnell Laura I. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:36 PM
Stevens Ruth E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:36 PM
Lee John H. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:38 PM
Salva Francisco D. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:40 PM
Druker Brian (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:06 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:21 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
8:00 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VINC) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners